0,843  0,006  Caspase 9 stimulant
0,833  0,003  Antimutagenic
0,781  0,006  GST A substrate
0,757  0,010  TNF expression inhibitor
0,748  0,004  Superoxide dismutase inhibitor
0,741  0,007  Sensitization
0,728  0,005  CTGF expression inhibitor
0,713  0,019  Antineoplastic (breast cancer)
0,694  0,010  Chemoprotective
0,662  0,009  Vasodilator, peripheral
0,657  0,005  Ulceration
0,665  0,037  Apoptosis agonist
0,632  0,007  Antipyretic
0,627  0,002  Succinate dehydrogenase inhibitor
0,628  0,007  Amyloid beta aggregation inhibitor
0,621  0,003  GST P1-1 substrate
0,623  0,009  Antipruritic, allergic
0,638  0,027  Transcription factor NF kappa B inhibitor
0,622  0,016  Aldehyde oxidase inhibitor
0,611  0,010  Antioxidant
0,613  0,017  Cholesterol antagonist
0,604  0,008  Free radical scavenger
0,607  0,016  Antihypercholesterolemic
0,589  0,005  Antihypoxic
0,599  0,021  CYP2C9 substrate
0,578  0,016  Radioprotector
0,565  0,005  UGT1A3 substrate
0,559  0,004  VCAM1 expression inhibitor
0,574  0,028  Antileukemic
0,552  0,008  UGT1A1 substrate
0,558  0,016  Chemopreventive
0,546  0,005  Sulfotransferase substrate
0,553  0,014  NOS2 expression inhibitor
0,536  0,006  UGT2B4 substrate
0,564  0,035  Antineoplastic (lung cancer)
0,542  0,018  Antineoplastic (cervical cancer)
0,537  0,014  FMO1 substrate
0,541  0,018  Histamine release inhibitor
0,524  0,016  Lipoxygenase inhibitor
0,523  0,018  AR expression inhibitor
0,502  0,005  NOS3 expression enhancer
0,507  0,011  Antihypertriglyceridemic
0,514  0,018  Apoptosis antagonist
0,513  0,018  Proliferative diseases treatment
0,500  0,008  Monophenol monooxygenase inhibitor
0,494  0,004  Cystathionine beta-synthase inhibitor
0,505  0,017  Antineoplastic (non-small cell lung cancer)
0,510  0,023  CYP1A2 substrate
0,509  0,026  Antiallergic
0,495  0,013  UGT1A6 substrate
0,485  0,008  Melanin inhibitor
0,505  0,031  Prostate cancer treatment
0,476  0,006  Amylase inhibitor
0,484  0,022  UGT1A9 substrate
0,491  0,030  Antithrombotic
0,477  0,019  Vasodilator, coronary
0,465  0,010  Anesthetic general
0,472  0,025  Caspase 3 stimulant
0,451  0,004  Carbonic anhydrase VI inhibitor
0,472  0,031  CYP2C19 substrate
0,443  0,008  Platelet adhesion inhibitor
0,453  0,021  Antiamyloidogenic
0,464  0,034  CYP2C19 inhibitor
0,450  0,021  Hypoglycemic
0,448  0,024  Cardiovascular analeptic
0,427  0,004  Prostaglandin EP2 antagonist
0,508  0,084  Antiinflammatory
0,437  0,014  Calcium channel activator
0,447  0,034  CYP2D6 substrate
0,447  0,035  Antineoplastic (ovarian cancer)
0,419  0,011  Tubulin antagonist
0,434  0,028  ICAM1 expression inhibitor
0,408  0,009  Antipruritic, non-allergic
0,415  0,017  Antineoplastic (lymphocytic leukemia)
0,394  0,004  Carbonic anhydrase III inhibitor
0,393  0,003  Keratolytic
0,435  0,046  Antineoplastic (colorectal cancer)
0,402  0,013  Antiseptic
0,418  0,034  NOS3 expression inhibitor
0,392  0,009  Tyrosine 3 hydroxylase inhibitor
0,395  0,013  Skin whitener
0,409  0,027  DNA damaging
0,391  0,010  Pneumotoxic
0,394  0,017  P-glycoprotein inhibitor
0,412  0,036  Cardioprotectant
0,379  0,004  Histidine decarboxylase inhibitor
0,397  0,023  Antimitotic
0,376  0,004  Carbonic anhydrase XIII inhibitor
0,399  0,028  Radiosensitizer
0,381  0,010  DNA methyltransferase I inhibitor
0,398  0,030  Antiprotozoal (Leishmania)
0,390  0,022  Pyruvate kinase inhibitor
0,371  0,004  Choleretic
0,413  0,046  Bone diseases treatment
0,389  0,022  Peroxidase inhibitor
0,413  0,047  Antineoplastic (colon cancer)
0,393  0,028  Antineoplastic (lymphoma)
0,381  0,015  GST M1-1 substrate
0,405  0,039  Antineoplastic (melanoma)
0,394  0,028  Platelet antagonist
0,383  0,019  Abortion inducer
0,371  0,008  Insulin sensitizer
0,385  0,022  Antiulcerative
0,425  0,064  5 Hydroxytryptamine release inhibitor
0,393  0,033  CYP1A2 inhibitor
0,399  0,040  Antineoplastic (brain cancer)
0,360  0,006  Cholesterol synthesis inhibitor
0,383  0,030  Tumour necrosis factor alpha release inhibitor
0,393  0,040  Lipoprotein disorders treatment
0,368  0,019  Skin irritative effect
0,388  0,040  Antiosteoporotic
0,352  0,006  Expectorant
0,352  0,007  GABA C receptor agonist
0,373  0,028  Antineoplastic (osteosarcoma)
0,360  0,016  UGT2B7 substrate
0,372  0,029  Nitric oxide antagonist
0,363  0,022  5 Hydroxytryptamine uptake stimulant
0,358  0,019  Non-steroidal antiinflammatory agent
0,355  0,016  DNA methylase inhibitor
0,418  0,081  Antidiabetic
0,418  0,081  Cyclophilin D inhibitor
0,349  0,012  Protein kinase stimulant
0,380  0,050  Hepatic disorders treatment
0,335  0,007  Interleukin 1b antagonist
0,361  0,033  Antidiabetic symptomatic
0,354  0,029  Sigma receptor agonist
0,355  0,034  FMO3 substrate
0,355  0,035  Mutagenic
0,342  0,024  Eye irritation, high
0,394  0,077  15-Lipoxygenase inhibitor
0,365  0,049  Teratogen
0,328  0,012  Antidote
0,343  0,027  UDP-glucuronosyltransferase substrate
0,348  0,035  Insulysin inhibitor
0,322  0,009  Interleukin 1 antagonist
0,345  0,037  Antineoplastic (renal cancer)
0,320  0,017  Phospholipase C inhibitor
0,340  0,036  Transcription factor STAT3 inhibitor
0,339  0,036  Vasodilator
0,337  0,040  Carcinogenic
0,303  0,005  Phobic disorders treatment
0,341  0,046  Sodium/bile acid cotransporter inhibitor
0,342  0,048  Antineoplastic (glioma)
0,366  0,072  CYP3A4 substrate
0,309  0,016  UGT2B15 substrate
0,309  0,017  Protein-tyrosine phosphatase inhibitor
0,328  0,036  Interleukin agonist
0,305  0,016  Alpha-N-acetylglucosaminidase inhibitor
0,338  0,049  Hypoxia-inducible factor 1 alpha inhibitor
0,347  0,058  12-Lipoxygenase inhibitor
0,295  0,006  Catalase inhibitor
0,294  0,005  UGT2B10 substrate
0,299  0,011  5-Lipoxygenase inhibitor
0,314  0,026  Antihypotensive
0,293  0,005  HIV-1 integrase (3'-Processing) inhibitor
0,341  0,055  Spasmolytic
0,301  0,018  CYP2B6 inhibitor
0,310  0,027  Hepatoprotectant
0,292  0,010  Cell adhesion inhibitor
0,291  0,010  Carcinogenic, group 2B
0,341  0,060  Antipsoriatic
0,302  0,023  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,297  0,019  Antihelmintic (Nematodes)
0,296  0,021  Restenosis treatment
0,278  0,005  Vanilloid 1 agonist
0,277  0,004  Heat shock protein 70 antagonist
0,333  0,061  5 Hydroxytryptamine release stimulant
0,292  0,019  Tumour necrosis factor antagonist
0,282  0,011  LDLR expression enhancer
0,323  0,052  Antineoplastic (multiple myeloma)
0,322  0,054  Embryotoxic
0,288  0,022  Interferon gamma antagonist
0,311  0,045  Vascular (periferal) disease treatment
0,310  0,046  Interleukin antagonist
0,279  0,016  Glutathione S-transferase substrate
0,298  0,036  Platelet aggregation inhibitor
0,279  0,019  Genotoxic
0,265  0,005  HIV-1 integrase (Strand Transfer) inhibitor
0,281  0,022  Lipid peroxidase inhibitor
0,317  0,059  Antineoplastic (small cell lung cancer)
0,263  0,005  ABCA1 expression enhancer
0,304  0,050  Antineoplastic (liver cancer)
0,278  0,025  Antiacne
0,305  0,053  Transcription factor STAT inhibitor
0,263  0,013  Uterine stimulant
0,269  0,019  Phospholipase A2 inhibitor
0,298  0,049  Hypolipemic
0,289  0,041  Gastrin inhibitor
0,257  0,010  Alcohol dehydrogenase substrate
0,297  0,051  Angiogenesis stimulant
0,295  0,049  Antineoplastic (glioblastoma multiforme)
0,297  0,053  Cardiodepressant
0,252  0,009  Breast cancer-resistant protein inhibitor
0,294  0,051  Antiglaucomic
0,258  0,016  Antifungal enhancer
0,293  0,052  Myocardial infarction treatment
0,276  0,035  UGT1A4 substrate
0,258  0,018  UGT2B9 substrate
0,260  0,023  Liver fibrosis treatment
0,243  0,006  NAD(P)H dehydrogenase (quinone) inhibitor
0,285  0,049  DNA synthesis inhibitor
0,248  0,012  Xanthine oxidase inhibitor
0,308  0,072  Respiratory analeptic
0,261  0,026  Carcinogenic, group 3
0,331  0,097  Immunosuppressant
0,244  0,009  Antirickettsial
0,247  0,013  Mannose-6-phosphate isomerase inhibitor
0,243  0,010  Mediator release inhibitor
0,238  0,005  Carbonic anhydrase V inhibitor
0,243  0,010  Toll-Like receptor 2 antagonist
0,237  0,005  Macrophage migration inhibitory factor inhibitor
0,303  0,072  Antineoplastic (endocrine cancer)
0,263  0,031  Neurotrophic factor enhancer
0,239  0,009  Calcium antagonist
0,234  0,004  Ornithine decarboxylase inhibitor
0,256  0,029  Antineoplastic (squamous cell carcinoma)
0,240  0,012  Antieczematic
0,246  0,019  Carcinogenic, group 1
0,249  0,023  Corneal wound healing stimulator
0,281  0,057  Cytostatic
0,254  0,031  Acaricide
0,241  0,018  Protein-tyrosine phosphatase 1B inhibitor
0,235  0,013  Microtubule formation inhibitor
0,239  0,017  ATPase inhibitor
0,223  0,005  Leukotriene antagonist
0,290  0,073  Antineoplastic (pancreatic cancer)
0,220  0,004  Prostaglandin EP3 antagonist
0,232  0,019  SULT1A3 substrate
0,224  0,014  SULT1A1 substrate
0,244  0,035  Amyloid beta precursor protein antagonist
0,290  0,081  Analeptic
0,224  0,015  Arachidonic acid antagonist
0,216  0,008  Cell adhesion molecule inhibitor
0,212  0,005  Glutathione S-transferase inhibitor
0,325  0,118  Antibacterial
0,228  0,021  DNA polymerase I inhibitor
0,263  0,058  Cyclic AMP phosphodiesterase inhibitor
0,209  0,005  Carbonic anhydrase VA inhibitor
0,225  0,020  Chelator
0,208  0,004  Antifungal (Pneumocystis)
0,227  0,023  Antiprotozoal (Coccidial)
0,214  0,010  Mucolytic
0,253  0,053  Antineoplastic enhancer
0,225  0,028  VEGF expression inhibitor
0,211  0,014  UGT2B1 substrate
0,223  0,026  Neurotensin receptor agonist
0,231  0,035  Antineoplastic (carcinoma)
0,218  0,023  Antihyperlipoproteinemic
0,279  0,086  Antiischemic
0,236  0,044  Nitric-oxide synthase stimulant
0,204  0,012  Adenylate cyclase stimulant
0,219  0,028  Cyclooxygenase 1 inhibitor
0,245  0,054  Peptidyltransferase inhibitor
0,200  0,012  HIV-1 integrase (Overall Integration) inhibitor
0,195  0,007  Glutamate decarboxylase inhibitor
0,200  0,013  Dementia treatment
0,194  0,008  Beta tubulin antagonist
0,257  0,073  Antineoplastic (bladder cancer)
0,300  0,116  CYP2C9 inhibitor
0,239  0,056  Septic shock treatment
0,259  0,076  Flavin-containing monooxygenase substrate
0,186  0,004  Carbonic anhydrase XIV inhibitor
0,195  0,013  Vascular dementia treatment
0,195  0,014  Aldehyde dehydrogenase substrate
0,334  0,154  Antineoplastic (solid tumors)
0,262  0,083  Antidiabetic (type 2)
0,187  0,008  Toll-Like receptor 4 antagonist
0,184  0,006  UGT2B11 substrate
0,180  0,006  Carbonic anhydrase VB inhibitor
0,206  0,033  Insulin secretagoues
0,190  0,017  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,194  0,022  Excitatory amino acid transporter EAAC1 inhibitor
0,175  0,004  Leukotriene B4 antagonist
0,247  0,079  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,173  0,005  Transcription factor AP-1 inhibitor
0,318  0,151  Alpha-glucosidase inhibitor
0,234  0,067  Cytotoxic
0,190  0,023  Cyclooxygenase 3 inhibitor
0,181  0,015  TRPA1 agonist
0,189  0,025  Ferrochelatase inhibitor
0,180  0,017  Antispirochetal
0,287  0,125  GABA C receptor rho-3 antagonist
0,197  0,034  M18 aspartyl aminopeptidase inhibitor
0,181  0,022  Coagulant
0,176  0,016  Estrogen antagonist
0,165  0,010  Peroxisome proliferator-activated receptor gamma agonist
0,199  0,045  Hair growth stimulant
0,197  0,043  Cyclooxygenase inhibitor
0,276  0,123  Stroke treatment
0,171  0,018  Beta glucuronidase inhibitor
0,188  0,035  Raynaud's phenomenon treatment
0,162  0,009  Prostaglandin antagonist
0,209  0,056  Dual specificity phosphatase 3 inhibitor
0,159  0,006  GABA aminotransferase inhibitor
0,164  0,013  Thioredoxin inhibitor
0,174  0,024  Carbonic anhydrase XV inhibitor
0,155  0,006  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,187  0,040  Aldose reductase substrate
0,157  0,010  Aldose reductase inhibitor
0,190  0,044  MAO inhibitor
0,189  0,044  Anesthetic
0,163  0,019  Ca2+-transporting ATPase inhibitor
0,219  0,075  Antiparasitic
0,185  0,041  Cytokine production inhibitor
0,151  0,007  Xanthine dehydrogenase inhibitor
0,152  0,008  HIV-1 integrase inhibitor
0,147  0,004  Aconitate hydratase inhibitor
0,177  0,034  Aldehyde dehydrogenase inhibitor
0,251  0,109  Antifungal
0,159  0,017  DOPA decarboxylase inhibitor
0,159  0,018  Actinic keratosis treatment
0,174  0,033  Gout treatment
0,191  0,050  Aldehyde oxidase substrate
0,162  0,021  AMP-activated protein kinase stimulant
0,205  0,065  Antihelmintic
0,183  0,046  CNS active muscle relaxant
0,222  0,086  Neuropeptide Y2 antagonist
0,156  0,020  Prolactin inhibitor
0,213  0,077  Antiparkinsonian, rigidity relieving
0,144  0,008  Hyperparathyroidism treatment
0,167  0,034  Antiprotozoal (Amoeba)
0,217  0,083  Antiviral (West Nile virus)
0,146  0,013  Phenylalanine 4-hydroxylase inhibitor
0,141  0,009  Prostaglandin E2 antagonist
0,150  0,018  Phosphofructokinase-1 inhibitor
0,169  0,038  Alkylator
0,191  0,061  Muscle relaxant
0,176  0,046  GABA C receptor rho-2 antagonist
0,137  0,007  Peroxisome proliferator-activated receptor alpha agonist
0,190  0,060  Dual specificity phosphatase inhibitor
0,138  0,010  NMDA receptor agonist
0,132  0,004  Retinoid X alpha receptor agonist
0,158  0,030  Gastritis treatment
0,289  0,161  Antiarthritic
0,164  0,036  Antibacterial (Helicobacter pylori)
0,154  0,028  Antiviral (Papilloma)
0,134  0,008  Anticholelithogenic
0,149  0,023  Uric acid excretion stimulant
0,146  0,021  Triose-phosphate isomerase inhibitor
0,255  0,130  Thioredoxin glutathione reductase inhibitor
0,136  0,012  Alcohol oxidase inhibitor
0,201  0,077  Age-related macular degeneration treatment
0,247  0,122  Interleukin 2 agonist
0,127  0,004  Glucose-6-phosphate translocase inhibitor
0,161  0,039  Cathepsin H inhibitor
0,152  0,030  Photosensitizer
0,130  0,010  Granulocyte macrophage colony stimulating factor agonist
0,151  0,032  Sphingosine 1-phosphate receptor 4 antagonist
0,149  0,032  DNA repair enzyme inhibitor
0,121  0,005  Exportin-1 inhibitor
0,145  0,029  Gastric antisecretory
0,144  0,027  Sphingomyelinase inhibitor
0,146  0,031  Caspase 3 inhibitor
0,127  0,012  Alpha tubulin antagonist
0,130  0,015  Vanilloid agonist
0,152  0,037  MAO B inhibitor
0,154  0,039  Growth stimulant
0,118  0,004  Retinoid X receptor agonist
0,121  0,008  Endocannabinoid uptake inhibitor
0,166  0,054  Skeletal muscle relaxant
0,173  0,062  Antiviral (Hepatitis C)
0,135  0,024  Porphobilinogen synthase inhibitor
0,284  0,174  DNA polymerase beta inhibitor
0,140  0,030  Adenylate kinase inhibitor
0,161  0,052  Antianemic
0,128  0,020  Glutamate dehydrogenase inhibitor
0,115  0,008  Plasminogen activator inhibitor antagonist
0,145  0,038  Contraceptive female
0,213  0,107  Antineoplastic (sarcoma)
0,238  0,132  Angiogenesis inhibitor
0,129  0,024  NADH dehydrogenase inhibitor
0,114  0,010  NMDA receptor glycine site agonist
0,131  0,028  GST T1-1 substrate
0,180  0,077  Antiviral (Hepatitis)
0,121  0,019  ATPase (Vacuolar H+) inhibitor
0,119  0,017  Thioredoxin reductase inhibitor
0,125  0,024  Antidote, mercury
0,132  0,032  Acetylcholine release stimulant
0,133  0,033  Electron transport complex I inhibitor
0,214  0,115  5 Hydroxytryptamine 1E antagonist
0,103  0,005  Prostaglandin agonist
0,172  0,074  Antineoplastic (bone cancer)
0,108  0,012  GABA B receptor agonist
0,273  0,177  DNA directed DNA polymerase inhibitor
0,098  0,004  Retinoid X gamma receptor agonist
0,105  0,010  Antiviral (Parainfluenza)
0,119  0,024  Antifungal (Candida)
0,109  0,016  Estrogen-related receptor beta agonist
0,098  0,004  Retinoic acid alpha receptor agonist
0,105  0,013  Peroxisome proliferator-activated receptor gamma antagonist
0,266  0,176  Transcription factor inhibitor
0,119  0,029  Antiviral (Rhinovirus)
0,196  0,106  RNA-directed DNA polymerase inhibitor
0,123  0,033  Carcinogenic, group 2A
0,167  0,077  3C-like protease (Human coronavirus) inhibitor
0,093  0,003  Kainate receptor agonist
0,093  0,004  Retinoid X beta receptor agonist
0,117  0,028  Phosphodiesterase 6D inhibitor
0,146  0,057  Cyclooxygenase 2 inhibitor
0,119  0,031  Antifungal (Aspergillus)
0,169  0,082  Myocardial ischemia treatment
0,204  0,117  Immunostimulant
0,127  0,041  Bronchodilator
0,122  0,038  GABA C receptor rho-1 antagonist
0,146  0,062  Alkaline phosphatase inhibitor
0,144  0,060  Farnesoid X receptor antagonist
0,105  0,023  Leukotriene synthesis inhibitor
0,087  0,005  Prostaglandin EP4 antagonist
0,116  0,035  Glutamate (mGluR7) agonist
0,094  0,014  Glutamate (mGluR7) antagonist
0,099  0,019  Biliverdin reductase inhibitor
0,097  0,018  Antitreponemal
0,088  0,009  Thromboxane synthase inhibitor
0,186  0,107  ErbB-1 antagonist
0,100  0,021  Glycine receptor agonist
0,089  0,011  Carbonic anhydrase VII inhibitor
0,084  0,007  Peroxisome proliferator-activated receptor delta agonist
0,103  0,025  Estrogen receptor alpha antagonist
0,162  0,085  Antianginal
0,083  0,006  Factor III inhibitor
0,084  0,008  Glucose-6-phosphate isomerase inhibitor
0,154  0,079  Thrombolytic
0,079  0,004  GABA transporter 3 inhibitor
0,081  0,006  Heparanase inhibitor
0,086  0,012  Transcription factor RelA inhibitor
0,089  0,015  SULT2A1 substrate
0,078  0,004  Leukotriene B4 receptor 1 antagonist
0,078  0,004  Retinoic acid receptor agonist
0,116  0,043  Anabolic
0,113  0,040  Alcohol dehydrogenase inhibitor
0,108  0,035  Bile acid receptor antagonist
0,131  0,059  Papain-like protease (SARS coronavirus) inhibitor
0,129  0,058  Beta amyloid protein antagonist
0,078  0,007  Fumarate hydratase inhibitor
0,099  0,028  CDC25A inhibitor
0,083  0,013  Glutamate (mGluR group III) agonist
0,134  0,064  Antihemorrhagic
0,262  0,193  Calcium channel L-type activator
0,078  0,010  Lysophosphatidic acid 3 receptor antagonist
0,071  0,004  Retinoid X receptor antagonist
0,081  0,014  Heme oxygenase stimulant
0,159  0,093  Antineoplastic (gastric cancer)
0,123  0,057  Interleukin 8 antagonist
0,094  0,028  Sphingosine 1-phosphate receptor 4 agonist
0,147  0,082  Hexokinase inhibitor
0,087  0,022  CDC25B inhibitor
0,144  0,079  Antidiarrheal
0,070  0,005  Prostaglandin E2 agonist
0,127  0,062  Adenylate cyclase inhibitor
0,117  0,052  HDL-cholesterol increasing
0,068  0,003  Retinoic acid alpha receptor antagonist
0,075  0,010  Leukotriene C antagonist
0,124  0,060  Antiviral (Influenza B)
0,173  0,109  Histone acetyltransferase inhibitor
0,162  0,099  Antieczematic atopic
0,128  0,066  Antineoplastic (uterine cancer)
0,132  0,070  Cocaine dependence treatment
0,074  0,013  Ryanodine receptor antagonist
0,072  0,012  Pregnane X receptor antagonist
0,096  0,035  Na+ K+ transporting ATPase inhibitor
0,065  0,005  Glutamate (mGluR8) agonist
0,098  0,038  Myeloperoxidase inhibitor
0,136  0,077  Antiparkinsonian, tremor relieving
0,062  0,004  Retinoic acid receptor antagonist
0,079  0,020  Thromboxane antagonist
0,115  0,056  Antihelmintic (Fasciola)
0,076  0,018  Phosphorylase inhibitor
0,073  0,015  DNA helicase inhibitor
0,082  0,024  Purinergic P2X1 antagonist
0,082  0,025  Protease 3C (Human rhinovirus) inhibitor
0,100  0,043  Glutamate release inhibitor
0,093  0,036  Cathepsin G inhibitor
0,128  0,071  Acetylcholinesterase inhibitor
0,060  0,004  Retinoid X alpha receptor antagonist
0,075  0,019  Glycine transporter 2 inhibitor
0,130  0,074  Sphingosine 1-phosphate receptor 2 antagonist
0,068  0,013  Adenylate cyclase 1 inhibitor
0,121  0,065  Antineoplastic antimetabolite
0,074  0,019  Thromboxane A2 antagonist
0,138  0,084  Sphingosine 1-phosphate receptor 5 antagonist
0,093  0,039  D-Ala-D-Ala ligase inhibitor
0,153  0,100  Catenin beta inhibitor
0,062  0,009  Prostacyclin antagonist
0,079  0,026  Glutamate (mGluR6) antagonist
0,106  0,053  Creatine kinase inhibitor
0,057  0,005  Prostaglandin EP2 agonist
0,057  0,005  LFA antagonist
0,080  0,028  Carbamoyl phosphate synthetase inhibitor
0,074  0,022  Calcium channel P-type blocker
0,112  0,061  GABA C receptor antagonist
0,109  0,059  MAO A inhibitor
0,126  0,076  Interleukin 4 antagonist
0,140  0,091  Pulmonary hypertension treatment
0,110  0,061  Multidrug resistance-associated protein 1 inhibitor
0,128  0,079  Bone formation stimulant
0,104  0,056  UDP-glucose 4-epimerase inhibitor
0,135  0,087  Cytidine deaminase inhibitor
0,054  0,006  Kynurenine 3 monooxygenase inhibitor
0,091  0,043  Metalloproteinase-2 inhibitor
0,056  0,008  Sodium-dependent vitamin C transporter 2 inhibitor
0,060  0,012  Guanylate cyclase inhibitor
0,069  0,022  Postcoital contraceptive
0,048  0,003  Retinoid X gamma receptor antagonist
0,049  0,004  ICAM 1 antagonist
0,071  0,026  Postmenopausal disorders treatment
0,073  0,029  Antimycoplasmal
0,084  0,040  SULT1A2 substrate
0,167  0,123  Aryl hydrocarbon receptor agonist
0,084  0,040  Antidote, organophosphates
0,084  0,041  Metalloproteinase-9 inhibitor
0,071  0,028  Maillard reaction inhibitor
0,133  0,090  Antifungal (Cryptococcus)
0,090  0,047  Inducible nitric-oxide synthase inhibitor
0,050  0,007  NMDA 2D receptor antagonist
0,102  0,060  Estrogen receptor beta antagonist
0,050  0,008  Integrin alpha1beta1 antagonist
0,055  0,014  Dihydrofolate reductase inhibitor
0,050  0,010  Leukotriene C4 antagonist
0,089  0,049  Arylamine N-Acetyltransferase substrate
0,044  0,005  Leukotriene B4 receptor 2 antagonist
0,043  0,004  Retinoic acid gamma receptor agonist
0,046  0,007  Methionyl aminopeptidase 2 inhibitor
0,153  0,114  Psychostimulant
0,042  0,004  Retinoic acid beta receptor agonist
0,052  0,014  Farnesoid X receptor agonist
0,109  0,072  Myasthenia Gravis treatment
0,094  0,056  Paget's disease treatment
0,058  0,021  Estradiol 17 beta-dehydrogenase inhibitor
0,094  0,057  SULT1E1 substrate
0,047  0,011  Vanilloid 3 antagonist
0,126  0,090  Cell wall synthesis inhibitor
0,110  0,074  Anesthetic local
0,049  0,013  RNA-directed RNA polymerase inhibitor
0,041  0,006  Prostaglandin EP4 agonist
0,138  0,103  Mcl-1 antagonist
0,044  0,010  GABA transporter 2 inhibitor
0,039  0,006  Prostaglandin H2 antagonist
0,049  0,016  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,118  0,086  Antihelmintic (Trematoda)
0,034  0,004  Retinoid X beta receptor antagonist
0,042  0,011  Lysophosphatidic acid 2 receptor antagonist
0,060  0,030  Estrogen agonist
0,057  0,027  Vanilloid 2 antagonist
0,061  0,032  Acyl-CoA dehydrogenase inhibitor
0,055  0,027  Squalene epoxidase inhibitor
0,039  0,011  Glutamate (mGluR3) agonist
0,117  0,089  Toll-Like receptor antagonist
0,053  0,026  Potassium channel Kv1.3 blocker
0,046  0,019  GABA uptake inhibitor
0,065  0,038  Prostaglandin F2 alpha antagonist
0,040  0,013  Prostaglandin D2 agonist
0,045  0,018  Diamine oxidase inhibitor
0,069  0,042  MDM2 inhibitor
0,040  0,014  Catechol O-methyltransferase inhibitor
0,041  0,015  Free fatty acid receptor 1 antagonist
0,106  0,080  Topoisomerase II inhibitor
0,061  0,036  Botulinum neurotoxin type A inhibitor
0,084  0,058  Phosphodiesterase IV inhibitor
0,069  0,043  Selectin antagonist
0,030  0,005  GABA transporter inhibitor
0,065  0,040  Nitric oxide donor
0,044  0,019  Inosine monophosphate dehydrogenase inhibitor
0,029  0,004  Integrin beta2 antagonist
0,094  0,069  Aminopeptidase B inhibitor
0,079  0,054  Topoisomerase II alpha inhibitor
0,092  0,068  Interleukin 12 antagonist
0,039  0,015  Peroxisome proliferator-activated receptor delta antagonist
0,096  0,072  Urease inhibitor
0,031  0,008  Inosine monophosphate dehydrogenase 2 inhibitor
0,054  0,031  Anesthetic inhalation
0,073  0,050  Aminopeptidase I inhibitor
0,030  0,008  Integrin beta5 antagonist
0,038  0,017  HMG CoA reductase inhibitor
0,037  0,016  ATP citrate lysase inhibitor
0,058  0,038  Argininosuccinate synthase inhibitor
0,111  0,091  Retinoprotector
0,038  0,018  Glutamate (mGluR4) agonist
0,028  0,008  Lysophosphatidic acid 1 receptor antagonist
0,042  0,022  Cholesterol absorption inhibitor
0,031  0,011  Peroxisome proliferator-activated receptor alpha antagonist
0,033  0,014  Leukotriene D4 antagonist
0,022  0,004  Retinoic acid beta receptor antagonist
0,040  0,022  Kainate receptor 2 antagonist
0,134  0,116  Antipruritic
0,082  0,065  Transcription factor NF kappa B stimulant
0,117  0,100  Neurotrophic factor
0,036  0,020  Estrogen-related receptor alpha antagonist
0,105  0,089  Shock treatment
0,028  0,012  Prostaglandin D2 antagonist
0,061  0,045  Caspase 9 inhibitor
0,027  0,011  Prostaglandin F2 alpha agonist
0,131  0,115  CF transmembrane conductance regulator agonist
0,090  0,074  Electrolyte absorption antagonist
0,059  0,044  Antidote, heavy metal
0,026  0,011  Prostaglandin EP1 antagonist
0,085  0,070  Potassium channel (Ca-activated) activator
0,019  0,004  Retinoic acid receptor gamma antagonist
0,070  0,055  Histone deacetylase SIRT1 stimulant
0,070  0,055  Histone deacetylase stimulant
0,052  0,038  Matrix metalloproteinase 1 inhibitor
0,040  0,026  Membrane dipeptidase inhibitor
0,109  0,095  Renal failure treatment
0,018  0,005  Integrin alphaLbeta2 antagonist
0,068  0,055  Calcium channel L-type blocker
0,028  0,015  Thyroid hormone agonist
0,062  0,050  Aryl hydrocarbon receptor antagonist
0,069  0,057  Antibiotic
0,033  0,021  Nucleoside transporters inhibitor
0,020  0,008  Vesicular glutamate transport inhibitor
0,126  0,114  Neuropathy treatment
0,082  0,069  Interleukin 5 antagonist
0,021  0,009  Antibiotic Trimethoprim-like
0,086  0,075  Antiviral (Hepatitis A)
0,033  0,023  Histone deacetylase 5 inhibitor
0,016  0,005  Glutamate (mGluR6) agonist
0,062  0,052  Matrix metalloproteinase inhibitor
0,049  0,038  CD45 antagonist
0,024  0,014  Monocarboxylic acid transporter inhibitor
0,024  0,014  Monocarboxylic acid transporter 1 inhibitor
0,017  0,007  GABA transporter 1 inhibitor
0,028  0,019  Uridine phosphorylase inhibitor
0,057  0,049  NMDA 2C receptor antagonist
0,035  0,028  Glutamate (mGluR3) antagonist
0,050  0,043  Alpha-mannosidase inhibitor
0,164  0,157  5 Hydroxytryptamine 3E antagonist
0,017  0,010  Prostacyclin agonist
0,205  0,198  Antiasthmatic
0,038  0,032  VCAM-1 antagonist
0,046  0,040  Bombesin 2 receptor antagonist
0,183  0,177  Thyroid hormone antagonist
0,038  0,032  VCAM antagonist
0,033  0,027  Tubulin agonist
0,037  0,032  Integrin antagonist
0,016  0,011  Thromboxane A2 agonist
0,032  0,027  Melatonin receptor 1A agonist
0,024  0,019  VLA-4 antagonist
0,022  0,018  Isoleucine-tRNA ligase inhibitor
0,029  0,025  Squalene synthetase inhibitor
0,032  0,028  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,036  0,032  Vesicle monoamine transporter inhibitor
0,037  0,033  Dopamine D5 agonist
0,036  0,033  Kainate receptor antagonist
0,120  0,117  Thiol protease inhibitor
0,037  0,035  Liver X receptor alpha agonist
0,070  0,068  Narcotic antagonist
0,050  0,048  Sphingosine 1-phosphate receptor 5 agonist
0,031  0,029  Carnitine palmitoyltransferase 1 inhibitor
0,033  0,032  Tryptophan 5 hydroxylase inhibitor
0,010  0,008  Thromboxane agonist
0,049  0,048  Beta 1 adrenoreceptor antagonist
0,028  0,027  HCV NS5B polymerase inhibitor
0,033  0,032  Glutamate (mGluR8) antagonist
0,030  0,030  Carnitine palmitoyltransferase inhibitor
0,015  0,015  Free fatty acid receptor 1 agonist
0,040  0,040  Fructose-1,6-bisphosphatase inhibitor

